Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

but SARS-CoV-2 uses its Envelope protein as an ion-channel to neutralize their acidity and so enhance viral release. As well as broadening our theoretical understanding of the viral life cycle ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the pandemic ... biology staff scientist Morgan Abernathy; life science researcher Yu E.

In the graphics that follow, Scientific American presents detailed explanations, current as of mid-June, into how SARS-CoV-2 sneaks inside human cells, makes copies of itself and bursts out to ...

Scientists found that it can bind to human ACE2 receptors, similar to SARS-CoV-2 (the virus behind COVID-19). This suggests it has the potential for animal-to-human transmission. Experts note that ...

The Lumipulse G600II instrument (left) and the Lumipulse SARS-CoV-2 Ag kit (right), both manufactured by Fujirebio, which were used in this study for the quantification of SARS-CoV-2 in saliva ...